EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C13H9NOSe |
| Net Charge | 0 |
| Average Mass | 274.181 |
| Monoisotopic Mass | 274.98494 |
| SMILES | O=c1c2ccccc2[se]n1-c1ccccc1 |
| InChI | InChI=1S/C13H9NOSe/c15-13-11-8-4-5-9-12(11)16-14(13)10-6-2-1-3-7-10/h1-9H |
| InChIKey | DYEFUKCXAQOFHX-UHFFFAOYSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Chemical Roles: | antioxidant A substance that opposes oxidation or inhibits reactions brought about by dioxygen or peroxides. radical scavenger A role played by a substance that can react readily with, and thereby eliminate, radicals. |
| Biological Roles: | genotoxin A role played by a chemical compound to induce direct or indirect DNA damage. Such damage can potentially lead to the formation of a malignant tumour, but DNA damage does not lead inevitably to the creation of cancerous cells. antiviral agent A substance that destroys or inhibits replication of viruses. EC 5.1.3.2 (UDP-glucose 4-epimerase) inhibitor An EC 5.1.3.* (racemases acting on carbohydrates and derivatives) inhibitor that interferes with the action of UDP-glucose 4-epimerase (EC 5.1.3.2). EC 1.3.1.8 [acyl-CoA dehydrogenase (NADP(+))] inhibitor An EC 1.3.1.* (oxidoreductase acting on donor CH-CH group, NAD+ or NADP+ as acceptor) inhibitor that interferes with the action of acyl-CoA dehydrogenase (NADP+), EC 1.3.1.8. apoptosis inducer Any substance that induces the process of apoptosis (programmed cell death) in multi-celled organisms. EC 2.5.1.7 (UDP-N-acetylglucosamine 1-carboxyvinyltransferase) inhibitor An EC 2.5.1.* (non-methyl-alkyl or aryl transferase) inhibitor that interferes with the action of UDP-N-acetylglucosamine 1-carboxyvinyltransferase (EC 2.5.1.7). EC 3.1.3.25 (inositol-phosphate phosphatase) inhibitor An EC 3.1.3.* (phosphoric monoester hydrolase) inhibitor that interferes with the action of inositol-phosphate phosphatase (EC 3.1.3.25). EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor An EC 1.8.1.* (oxidoreductase acting on sulfur group of donors, NAD+ or NADP+ as acceptor) inhibitor that interferes with the action of trypanothione-disulfide reductase (EC 1.8.1.12). EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor A lipoxygenase inhibitor that interferes with the action of arachidonate 5-lipoxygenase (EC 1.13.11.34). antibacterial agent A substance (or active part thereof) that kills or slows the growth of bacteria. EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor An EC 3.4.22.* (cysteine endopeptidase) inhibitor that interferes with the action of SARS coronavirus main proteinase (EC 3.4.22.69). ferroptosis inhibitor Any substance that inhibits the process of ferroptosis (a type of programmed cell death dependent on iron and characterized by the accumulation of lipid peroxides) in organisms. anticoronaviral agent Any antiviral agent which inhibits the activity of coronaviruses. EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor A lipoxygenase inhibitor that interferes with the action of arachidonate 15-lipoxygenase (EC 1.13.11.33). EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor An EC 2.7.10.* (protein-tyrosine kinase) inhibitor that interferes with the action of receptor protein-tyrosine kinase (EC 2.7.10.1). antifungal agent An antimicrobial agent that destroys fungi by suppressing their ability to grow or reproduce. EC 3.5.4.1 (cytosine deaminase) inhibitor An EC 3.5.4.* (non-peptide cyclic amidine C-N hydrolase) inhibitor that interferes with the action of cytosine deaminase (EC 3.5.4.1). |
| Applications: | hypoglycemic agent A drug which lowers the blood glucose level. antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. antidepressant Antidepressants are mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. hepatoprotective agent Any compound that is able to prevent damage to the liver. enzyme mimic Any small molecule that mimics the action of an enzyme. antipsychotic agent Antipsychotic drugs are agents that control agitated psychotic behaviour, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. anti-inflammatory drug A substance that reduces or suppresses inflammation. neuroprotective agent Any compound that can be used for the treatment of neurodegenerative disorders. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| ebselen (CHEBI:77543) has role anti-inflammatory drug (CHEBI:35472) |
| ebselen (CHEBI:77543) has role antibacterial agent (CHEBI:33282) |
| ebselen (CHEBI:77543) has role anticoronaviral agent (CHEBI:149553) |
| ebselen (CHEBI:77543) has role antidepressant (CHEBI:35469) |
| ebselen (CHEBI:77543) has role antifungal agent (CHEBI:35718) |
| ebselen (CHEBI:77543) has role antineoplastic agent (CHEBI:35610) |
| ebselen (CHEBI:77543) has role antioxidant (CHEBI:22586) |
| ebselen (CHEBI:77543) has role antipsychotic agent (CHEBI:35476) |
| ebselen (CHEBI:77543) has role antiviral agent (CHEBI:22587) |
| ebselen (CHEBI:77543) has role apoptosis inducer (CHEBI:68495) |
| ebselen (CHEBI:77543) has role EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor (CHEBI:64996) |
| ebselen (CHEBI:77543) has role EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor (CHEBI:64964) |
| ebselen (CHEBI:77543) has role EC 1.3.1.8 [acyl-CoA dehydrogenase (NADP+)] inhibitor (CHEBI:78377) |
| ebselen (CHEBI:77543) has role EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor (CHEBI:77402) |
| ebselen (CHEBI:77543) has role EC 2.5.1.7 (UDP-N-acetylglucosamine 1-carboxyvinyltransferase) inhibitor (CHEBI:78379) |
| ebselen (CHEBI:77543) has role EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor (CHEBI:62434) |
| ebselen (CHEBI:77543) has role EC 3.1.3.25 (inositol-phosphate phosphatase) inhibitor (CHEBI:173094) |
| ebselen (CHEBI:77543) has role EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor (CHEBI:147285) |
| ebselen (CHEBI:77543) has role EC 3.5.4.1 (cytosine deaminase) inhibitor (CHEBI:78380) |
| ebselen (CHEBI:77543) has role EC 5.1.3.2 (UDP-glucose 4-epimerase) inhibitor (CHEBI:78384) |
| ebselen (CHEBI:77543) has role enzyme mimic (CHEBI:78152) |
| ebselen (CHEBI:77543) has role ferroptosis inhibitor (CHEBI:173084) |
| ebselen (CHEBI:77543) has role genotoxin (CHEBI:50902) |
| ebselen (CHEBI:77543) has role hepatoprotective agent (CHEBI:62868) |
| ebselen (CHEBI:77543) has role hypoglycemic agent (CHEBI:35526) |
| ebselen (CHEBI:77543) has role neuroprotective agent (CHEBI:63726) |
| ebselen (CHEBI:77543) has role radical scavenger (CHEBI:48578) |
| ebselen (CHEBI:77543) is a benzoselenazole (CHEBI:78151) |
| IUPAC Name |
|---|
| 2-phenyl-1,2-benzoselenazol-3(2H)-one |
| INNs | Source |
|---|---|
| ebselen | WHO MedNet |
| ebsélène | WHO MedNet |
| ebseleno | WHO MedNet |
| ebselenum | WHO MedNet |
| Synonyms | Source |
|---|---|
| 2-phenyl-1,2-benzoselenazol-3-one | SUBMITTER |
| DR-3305 | LINCS |
| DR3305 | LINCS |
| NSC-639762 | ChEMBL |
| NSC-757883 | ChEMBL |
| PZ 51 | ChemIDplus |
| Registry Numbers | Sources |
|---|---|
| Reaxys:164926 | Reaxys |
| CAS:60940-34-3 | ChemIDplus |
| Citations |
|---|